TY - JOUR T1 - Mixed Micelle Proliposomes for Preparation of Liposomes Containing Amphotericin B, <em>In-vitro</em> and <em>Ex-vivo</em> Studies JF - PDA Journal of Pharmaceutical Science and Technology JO - PDA J Pharm Sci Technol SP - 240 LP - 246 VL - 54 IS - 3 AU - M.N. Sarbolouki AU - S. Parsaee AU - P. Kosary Y1 - 2000/05/01 UR - http://journal.pda.org/content/54/3/240.abstract N2 - The aim of this work was to produce a form of injectable liposomes containing amphotericin B derived from mixed micelle proliposomes. Mixed micelles were derived from a mixture of lecithin/sodium cholate in aqueous media. The solubility of amphotericin B in proliposomes was studied as a function of lipid composition (total lipid concentration, molar ratio of lecithin/sodium cholate), and the dispersion media (pH, ionic strength, presence or absence of human serum albumin), and the temperature. The data show that micelle→liposome transformation occurs during the dilution of proliposomes containing amphotericin B. These transformations could be followed via transmission electron microscopy (TEM). Data related to dilution of proliposomes as well, show that under no circumstance there occurs any precipitation that might be assigned to the decreased solubility of amphotericin B. These indicate that the incorporated drug also participates during the transformation of the proliposomes into liposomes. It is thus concluded that mixed micelle proliposomes are prime candidates for the production of a form of injectable amphotericin B in liposomes. ER -